Free Trial
NASDAQ:MEDS

Wellgistics Health Q3 2026 Earnings Results & Report

Wellgistics Health logo
$0.92 +0.05 (+5.19%)
As of 12:03 PM Eastern

Wellgistics Health reported Q3 2026 earnings on November 13, 2026. The company reported EPS of -$1.18.

Earnings Announcement Details

Quarter
Q3 2026
Time
Before Market Opens

Wellgistics Health EPS Results

Actual EPS
-$1.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Wellgistics Health Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Wellgistics Health Q3 2026 Earnings FAQ

Wellgistics Health (NASDAQ:MEDS) reported earnings of -$1.18 per share for Q3 2026. The report was announced on Friday, November 13, 2026.

Wellgistics Health Earnings Headlines

Wellgistics Health (MEDS) versus Its Competitors Critical Survey
Wellgistics Health (NASDAQ:MEDS) Stock Price Down 16.6% - Here's What Happened
I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
See More Wellgistics Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Wellgistics Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Wellgistics Health and other key companies, straight to your email.

About Wellgistics Health

Wellgistics Health (NASDAQ:MEDS) (NASDAQ: MEDS) is a healthcare technology and pharmaceutical services company focused on improving access to prescription medications. Through its platform and related services, the company connects pharmaceutical manufacturers, wholesalers, healthcare providers, pharmacies and patients within the prescription-drug supply chain.

The company provides technology and logistical solutions intended to support medication ordering, distribution and fulfillment. Its offerings are designed to help independent pharmacies and other healthcare participants manage prescription access, streamline supply-chain processes and serve patients more efficiently.

Wellgistics Health operates in the U.S. healthcare and pharmaceutical distribution market. The company’s business model combines software-enabled healthcare services with pharmaceutical supply-chain capabilities, although specific details about its geographic footprint, leadership and product portfolio may change as the company expands.

View Wellgistics Health Profile